Global Lysosomal Alpha Glucosidase Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Lysosomal Alpha Glucosidase Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Lysosomal Alpha Glucosidase report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lysosomal Alpha Glucosidase market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Glycogen Storage Disease and Pompe Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Lysosomal Alpha Glucosidase industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Lysosomal Alpha Glucosidase key manufacturers include Amicus Therapeutics Inc, Audentes Therapeutics Inc, Etubics Corp, Genzyme Corp, greenovation Biotech GmbH, Huons Co Ltd, JCR Pharmaceuticals Co Ltd, Oxyrane Belgium NV and Pharming Group NV, etc. Amicus Therapeutics Inc, Audentes Therapeutics Inc, Etubics Corp are top 3 players and held % sales share in total in 2022.
Lysosomal Alpha Glucosidase can be divided into AT-982, ATB-200, AVRRD-03 and JR-162, etc. AT-982 is the mainstream product in the market, accounting for % sales share globally in 2022.
Lysosomal Alpha Glucosidase is widely used in various fields, such as Glycogen Storage Disease, Pompe Disease and Others,, etc. Glycogen Storage Disease provides greatest supports to the Lysosomal Alpha Glucosidase industry development. In 2022, global % sales of Lysosomal Alpha Glucosidase went into Glycogen Storage Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lysosomal Alpha Glucosidase market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Amicus Therapeutics Inc
Audentes Therapeutics Inc
Etubics Corp
Genzyme Corp
greenovation Biotech GmbH
Huons Co Ltd
JCR Pharmaceuticals Co Ltd
Oxyrane Belgium NV
Pharming Group NV
Sarepta Therapeutics Inc
Segment by Type
AT-982
ATB-200
AVRRD-03
JR-162
MOSS-GAA
OXY-2810
Others
Glycogen Storage Disease
Pompe Disease
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lysosomal Alpha Glucosidase market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lysosomal Alpha Glucosidase, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lysosomal Alpha Glucosidase industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Lysosomal Alpha Glucosidase in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lysosomal Alpha Glucosidase introduction, etc. Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Lysosomal Alpha Glucosidase market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Lysosomal Alpha Glucosidase industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Lysosomal Alpha Glucosidase key manufacturers include Amicus Therapeutics Inc, Audentes Therapeutics Inc, Etubics Corp, Genzyme Corp, greenovation Biotech GmbH, Huons Co Ltd, JCR Pharmaceuticals Co Ltd, Oxyrane Belgium NV and Pharming Group NV, etc. Amicus Therapeutics Inc, Audentes Therapeutics Inc, Etubics Corp are top 3 players and held % sales share in total in 2022.
Lysosomal Alpha Glucosidase can be divided into AT-982, ATB-200, AVRRD-03 and JR-162, etc. AT-982 is the mainstream product in the market, accounting for % sales share globally in 2022.
Lysosomal Alpha Glucosidase is widely used in various fields, such as Glycogen Storage Disease, Pompe Disease and Others,, etc. Glycogen Storage Disease provides greatest supports to the Lysosomal Alpha Glucosidase industry development. In 2022, global % sales of Lysosomal Alpha Glucosidase went into Glycogen Storage Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lysosomal Alpha Glucosidase market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Amicus Therapeutics Inc
Audentes Therapeutics Inc
Etubics Corp
Genzyme Corp
greenovation Biotech GmbH
Huons Co Ltd
JCR Pharmaceuticals Co Ltd
Oxyrane Belgium NV
Pharming Group NV
Sarepta Therapeutics Inc
Segment by Type
AT-982
ATB-200
AVRRD-03
JR-162
MOSS-GAA
OXY-2810
Others
Segment by Application
Glycogen Storage Disease
Pompe Disease
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lysosomal Alpha Glucosidase market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lysosomal Alpha Glucosidase, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lysosomal Alpha Glucosidase industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Lysosomal Alpha Glucosidase in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lysosomal Alpha Glucosidase introduction, etc. Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Lysosomal Alpha Glucosidase market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.